OGI

OrganiGram Holdings Inc
NASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Key Statistics

Market Cap
$130.67M
P/E Ratio
2.15
EPS
$0.43
Beta
1.91
52W High
$2.24
52W Low
$0.85
50-Day MA
$1.10
200-Day MA
$1.24
Dividend Yield
—
Profit Margin
28.00%
Forward P/E
15.67
PEG Ratio
—

About OrganiGram Holdings Inc

Organigram Holdings Inc. produces and sells cannabis and cannabis-derived products in Canada. The company is headquartered in Moncton, Canada.

Official WebsiteUSAFY End: September

Fundamentals

Revenue (TTM)$309.18M
Gross Profit (TTM)$112.98M
EBITDA$16.43M
Operating Margin5.04%
Return on Equity17.60%
Return on Assets-0.60%
Revenue/Share (TTM)$2.27
Book Value$2.43
Price-to-Book0.47
Price-to-Sales (TTM)0.43
EV/Revenue0.796
EV/EBITDA13.37
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)49.40%
Shares Outstanding$141.01M
Float$97.33M
% Insiders31.06%
% Institutions6.53%

Historical Volatility

HV 10-Day
32.88%
HV 20-Day
43.78%
HV 30-Day
38.63%
HV 60-Day
51.37%
HV Rank
9.5%

Volatility is currently contracting

Analyst Ratings

Consensus ($8.80 target)
1
Strong Buy
3
Buy
1
Hold

Latest News

Organigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on X

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram") is pleased to announce that the 2026 OG Investor Session will premiere today, September 30, 2026, at 4:00 p.m. ET on the Company's X account at https://x.com/Organigram_Inc. The session will also be simulcast on Organigram's LinkedIn and YouTube channels. “We designed this year's OG Investor Session around the questions we hear most often from investors — where the next phase of growth come.

Business Wire9/30/2026Neutral
Organigram Global to Host 2026 OG Investor Session

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform, today announced details of its 2026 OG Investor Session. “Since our last investor session, we've welcomed a new leadership team, completed our first full quarter with Sanity Group, and sharpened our strategy for the years ahead. We look forward to updating our stakeholders on how we're aligning Organigram.

Business Wire9/2/2026Neutral
Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram” or the “Company”) today announced an important milestone in its global growth strategy through the accelerated integration of Sanity Group GmbH (“Sanity”) and the alignment of leadership, operations and market development activities across the combined organization. To support the combined organization, Organigram has appointed Finn Age Hänsel as President, Rest of World & Chief Strategy Officer, and Adr.

Business Wire8/20/2026Neutral
Organigram Global Q3 Earnings Call Highlights

Organigram Global NASDAQ: OGI reported record third-quarter fiscal 2026 revenue and adjusted EBITDA, aided by the consolidation of Germany-based Sanity Group and improving performance in several Canadian cannabis categories.

MarketBeat8/11/2026Positive
Organigram Reports Record Third Quarter Fiscal 2026 Results

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share2 and a growing global cannabis platform following its acquisition of Sanity Group GmbH (“Sanity” or “Sanity Group”), today announced its results for the third quarter ended June 30, 2026 (“Q3 Fiscal 2026” or “Q3”). Q3 FISCAL 2026 HIGHLIGHTS Gross Revenue: $145.1 million (+32% year-over-year). Net Revenue: $105.8 million (+49% year-over-year). A.

Business Wire8/11/2026Neutral
Organigram to Report Third Quarter Fiscal 2026 Results on August 11, 2026

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share and a growing global cannabis platform following its acquisition of Sanity Group GmbH (“Sanity”), announced today it will report earnings results for its third quarter ended June 30, 2026, on Tuesday, August 11, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, Aug.

Business Wire8/4/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on OGI and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 10/17/2026